What is Samantha Fisher's NPI number?

Samantha Fisher's National Provider Identifier (NPI) is 1114124542, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Samantha Fisher's specialty?

Samantha Fisher is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Samantha Fisher located?

Samantha Fisher's practice location on file with NPPES is 2235 Venetian Court, Naples, FL 34109-8728.

What is Samantha Fisher's phone number?

The practice phone number listed in the NPPES registry for Samantha Fisher is (239) 596-9337.

Does Samantha Fisher accept Medicare?

Samantha Fisher is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Samantha Fisher's NPI active?

Yes — Samantha Fisher's NPI (1114124542) is active in the NPPES registry as of the last update on 2012-08-29.

IndividualActiveAccepts Medicare

Samantha Fisher, M.D.

NPI 1114124542 · Dermatology Physician · Naples, FL

Samantha Fisher, M.D. is a Dermatology Physician provider in Naples, FL (NPI 1114124542).

Provider details

NPI number: 1114124542
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: TRN11499 (FL)

Practice location

2235 Venetian Court

Suite 1

Naples, FL 34109-8728

Phone: (239) 596-9337

Fax: (239) 596-9466

Street-level locationGet directions

More FL providers

Mailing address

2235 Venetian Court

Naples, FL 34109-8728

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense ME106710 (FL)
Allopathic & Osteopathic Physicians
Internal Medicine Physician207R00000XLicense TRN11499 (FL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(87/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
5,546 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,158	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	795	$92
Destruction of Precancer Skin Growth, 1 Growth17000	705	$51
Biopsy of Related Skin Growth, First Growth11102	441	$91
Biopsy of Related Skin Growth, Each Additional Growth11103	273	$50
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	205	185
Doxycycline Hyclate	159	136
Betamethasone Dipropionate	87	65
Triamcinolone Acetonide	81	76
Ketoconazole	50	36
Ciclopirox Olaminebrand: Ciclopirox	47	34
Valacyclovir Hclbrand: Valacyclovir	36	20
Clobetasol Propionate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$394 across 16 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-06-29
Last updated: 2012-08-29

Frequently asked questions

What is Samantha Fisher's NPI number?: Samantha Fisher's National Provider Identifier (NPI) is 1114124542, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Samantha Fisher's specialty?: Samantha Fisher is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Samantha Fisher located?: Samantha Fisher's practice location on file with NPPES is 2235 Venetian Court, Naples, FL 34109-8728.
What is Samantha Fisher's phone number?: The practice phone number listed in the NPPES registry for Samantha Fisher is (239) 596-9337.
Does Samantha Fisher accept Medicare?: Samantha Fisher is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Samantha Fisher's NPI active?: Yes — Samantha Fisher's NPI (1114124542) is active in the NPPES registry as of the last update on 2012-08-29.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,158	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	795	$92
Destruction of Precancer Skin Growth, 1 Growth17000	705	$51
Biopsy of Related Skin Growth, First Growth11102	441	$91
Biopsy of Related Skin Growth, Each Additional Growth11103	273	$50
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	205	185
Doxycycline Hyclate	159	136
Betamethasone Dipropionate	87	65
Triamcinolone Acetonide	81	76
Ketoconazole	50	36
Ciclopirox Olaminebrand: Ciclopirox	47	34
Valacyclovir Hclbrand: Valacyclovir	36	20
Clobetasol Propionate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$394 across 16 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments